Skip to content

Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle

Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04758260
Acronym
Mioxsys ox
Enrollment
0
Registered
2021-02-17
Start date
2019-02-12
Completion date
2021-02-12
Last updated
2021-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)

Brief summary

Evaluate the influence of antioxidant men supplements treatment (Fertybiotic Hombre) in the rate of sORP (stactic Oxidation Reduction Potential) defined as the balanced measure between the total oxidant activity (ROS, superoxides, nitric oxide, peroxide) and total reducing activity (alpha tocopherol, β carotene, uric acid) in sperm samples during egg donation cycles. We will also evaluate the influence of the sORP rate in the embryo development during the egg donation treatments; taking in account the fecundation rate, percentage of blastocyst stage arrival embryos, number of frozen embryos, implantation rate, on-going pregnancy rate and miscarriage rate. The sperm sample will be measured by electrochemical technology using Mioxsys system for a quantitative measurement in millivolts (mV), in those male patients who participate in an egg donation assisted reproduction treatment. After 14 days, the pregnancy stage will be available. This information will be obtained from the patient's clinical history using the human chorionic gonadotropin hormone (shCG) in blood. It will be performed either in our Clinic or externally within the usual practice derived from the treatment carried out. These values will be compared with the results obtained from sORP.

Interventions

DIETARY_SUPPLEMENTAntioxidant

Oral antioxidant oral intake in the 3 months prior to inclusion in the study

Sponsors

Aytu BioPharma, Inc.
CollaboratorINDUSTRY
IVI Bilbao
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 48 Years
Healthy volunteers
No

Inclusion criteria

Male Inclusion Criteria * Sperm count greater than 2 million per milliliter * Sperm origin: ejaculate

Exclusion criteria

* Taking oral antioxidants in the 3 months prior to inclusion in the study * Total astenozoospermia or Severe teratozoospermia (including balloonzoospermia)

Design outcomes

Primary

MeasureTime frameDescription
Compare the sORP rate in sperm samples,2.5 monthsCompare the sORP rate in sperm samples, obtained by the Mioxsys System, before and after 2.5 months antioxidant men supplements treatment (Fertybiotic MAN).

Secondary

MeasureTime frameDescription
Evaluate the influence of the sORP rate in embryo development1 yearAnalysis of different embryo quality parameters as: * fecundation rate * percentage of blastocyst stage arrival embryos * number of frozen embryos
Evaluate the relationship between the sORP rate in sperm samples1 yearEvaluate the relationship between the sORP rate in sperm samples, obtained by Mioxsys System, with the implantation rate, on-going pregnancy rate and miscarriage rate.
Determinate a reproductive prognosis value based on sORP rate and the different sperm parameters1 year

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026